Venlafaxine - NDSRI's
References
FAQ's
References
- Husbands, George Edward Morris; Yardley, John Patrick; Muth, Eric Anthony, Phenethylamine Derivatives and Intermediates Therefor, American Home Products Corp., United States, EP112669B1, July 29, 1987
- Vu, Ryan Luan; Helmeste, Daiga; Albers, Lawrence; Reist, Christopher, Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection, Journal of Chromatography B: Biomedical Sciences and Applications, Volume: 703, Issue: 1 + 2, Pages: 195-201, 1997
Frequently Asked Questions
What are the challenges in the analysis of venlafaxine impurities?
The challenges faced during Venlafaxine impurity analysis include the sensitivity of analytical methods and the potential variability of impurity levels between batches.
How are Venlafaxine impurities controlled during the manufacturing of the drug?
Impurities in Venlafaxine are controlled during manufacturing with process optimization, careful selection of raw materials, and appropriate analytical testing throughout the production process.
Which solvent helps in analyzing Venlafaxine impurities?
Methanol is a common solvent used to analyze Venlafaxine impurities.
How should Venlafaxine impurities be stored in terms of temperature?
The recommendation is to store Venlafaxine impurities at room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.